4.6 Article

Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study

期刊

ENDOSCOPY
卷 53, 期 4, 页码 402-410

出版社

GEORG THIEME VERLAG KG
DOI: 10.1055/a-1217-0155

关键词

-

资金

  1. UK National Institute for Health Research Health (NIHR) Health Technology Assessment (HTA) Programme [04/33/01]
  2. UK Medical Research Council (MRC)-NIHR Efficacy and Mechanism Evaluation (EME) Programme [09/800/08]
  3. NIHR HTA Programme [16/65/01]
  4. ECP by the Department of Health in England
  5. Permanente Medical Group, Inc.
  6. US National Cancer Institute [CA222035]
  7. Cancer Research UK Population Research Committee Programme Award [C53889/A25004]

向作者/读者索取更多资源

This study focused on intermediate-risk individuals undergoing CRC screening and found that the high-risk subgroup had a significantly higher CRC incidence compared to the low-risk subgroup. Surveillance was shown to significantly reduce CRC incidence in the high-risk subgroup.
Background Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously examined intermediate-risk patients from hospital data and identified a higher-risk subgroup who benefited from surveillance and a lower-risk subgroup who may not require surveillance. This study explored whether these findings apply in individuals undergoing CRC screening. Methods This retrospective study used data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention program (KPCP). Screening participants (50 - 74 years) classified as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). Lower- and higher-risk subgroups were defined using our previously identified baseline risk factors: higher-risk participants had incomplete colonoscopies, poor bowel preparation, adenomas >= 20 mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence in these subgroups and in the presence vs. absence of surveillance using Cox regression. Results Of 2291 intermediate-risk participants, 45 % were classified as higher risk. Median follow-up was 11.8 years. CRC incidence was higher in the higher-risk than lower-risk subgroup (hazard ratio [HR] 2.08, 95 % confidence interval [CI] 1.07 - 4.06). Surveillance reduced CRC incidence in higher-risk participants (HR 0.35, 95 %CI 0.14 - 0.86) but not statistically significantly so in lower-risk participants (HR 0.41, 95 %CI 0.12 - 1.38). Conclusion As previously demonstrated for hospital patients, screening participants classified as intermediate risk comprised two risk subgroups. Surveillance clearly benefited the higher-risk subgroup.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据